| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |